Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Reyes Tamez-Guerra is active.

Publication


Featured researches published by Reyes Tamez-Guerra.


Journal of Immunology | 2005

A Novel Mucosal Vaccine Based on Live Lactococci Expressing E7 Antigen and IL-12 Induces Systemic and Mucosal Immune Responses and Protects Mice against Human Papillomavirus Type 16-Induced Tumors

Luis G. Bermúdez-Humarán; François Lefèvre; Valeria Guimarães; Juan Manuel Alcocer-González; Jean-Jacques Gratadoux; Cristina Rodríguez-Padilla; Reyes Tamez-Guerra; Gérard Corthier; Alexandra Gruss; Philippe Langella

Current strategies to prevent or treat human papillomavirus type 16 (HPV-16) infection are promising, but remain costly. More economical but efficient vaccines are thus needed. In this study, we evaluated the protective effects of mucosally coadministered live Lactococcus lactis strains expressing cell wall-anchored E7 Ag and a secreted form of IL-12 to treat HPV-16-induced tumors in a murine model. When challenged with lethal levels of tumor cell line TC-1 expressing E7, immunized mice showed full prevention of TC-1-induced tumors, even after a second challenge, suggesting that this prophylactic immunization can provide long-lasting immunity. Therapeutic immunization with L. lactis recombinant strains, i.e., 7 days after TC-1 injection, induced regression of palpable tumors in treated mice. The antitumor effects of vaccination occurred through a CTL response, which is CD4+ and CD8+ dependent. Furthermore, immunized mice developed an E7-specific mucosal immune response. These preclinical results suggest the feasibility of the low-cost mucosal vaccination and/or immunotherapy strategies against HPV-related cervical cancer in humans.


Infection and Immunity | 2003

Intranasal Immunization with Recombinant Lactococcus lactis Secreting Murine Interleukin-12 Enhances Antigen-Specific Th1 Cytokine Production

Luis G. Bermúdez-Humarán; Philippe Langella; Alexandra Gruss; Reyes Tamez-Guerra; Sergio C. Oliveira; Odila Saucedo Cardenas; Roberto Montes de Oca-Luna; Yves Le Loir

ABSTRACT Interleukin-12 (IL-12), a heterodimeric cytokine, plays an important role in cellular immunity to several bacterial, viral, and parasitic infections and has adjuvant activity when it is codelivered with DNA vaccines. IL-12 has also been used with success in cancer immunotherapy treatments. However, systemic IL-12 therapy has been limited by high levels of toxicity. We describe here inducible expression and secretion of IL-12 in the food-grade lactic acid bacterium Lactococcus lactis. IL-12 was expressed as two separate polypeptides (p35-p40) or as a single recombinant polypeptide (scIL-12). The biological activity of IL-12 produced by the recombinant L. lactis strain was confirmed in vitro by its ability to induce gamma interferon (IFN-γ) production by mouse splenocytes. Local administration of IL-12-producing strains at the intranasal mucosal surface resulted in IFN-γ production in mice. The activity was greater with the single polypeptide scIL-12. An antigen-specific cellular response (i.e., secretion of Th1 cytokines, IL-2, and IFN-γ) elicited by a recombinant L. lactis strain displaying a cell wall-anchored human papillomavirus type 16 E7 antigen was dramatically increased by coadministration with an L. lactis strain secreting IL-12 protein. Our data show that IL-12 is produced and secreted in an active form by L. lactis and that the strategy which we describe can be used to enhance an antigen-specific immune response and to stimulate local mucosal immunity.


Journal of Experimental & Clinical Cancer Research | 2010

Antitumor activity of colloidal silver on MCF-7 human breast cancer cells

Moisés Armides Franco-Molina; Edgar Mendoza-Gamboa; Crystel A Sierra-Rivera; Ricardo Gomez-Flores; Pablo Zapata-Benavides; Paloma Castillo-Tello; Juan Manuel Alcocer-González; Diana F. Miranda-Hernández; Reyes Tamez-Guerra; Cristina Rodríguez-Padilla

BackgroundColloidal silver has been used as an antimicrobial and disinfectant agent. However, there is scarce information on its antitumor potential. The aim of this study was to determine if colloidal silver had cytotoxic effects on MCF-7 breast cancer cells and its mechanism of cell death.MethodsMCF-7 breast cancer cells were treated with colloidal silver (ranged from 1.75 to 17.5 ng/mL) for 5 h at 37°C and 5% CO2 atmosphere. Cell Viability was evaluated by trypan blue exclusion method and the mechanism of cell death through detection of mono-oligonucleosomes using an ELISA kit and TUNEL assay. The production of NO, LDH, and Gpx, SOD, CAT, and Total antioxidant activities were evaluated by colorimetric assays.ResultsColloidal silver had dose-dependent cytotoxic effect in MCF-7 breast cancer cells through induction of apoptosis, shown an LD50 (3.5 ng/mL) and LD100 (14 ng/mL) (*P < 0.05), significantly decreased LDH (*P < 0.05) and significantly increased SOD (*P < 0.05) activities. However, the NO production, and Gpx, CAT, and Total antioxidant activities were not affected in MCF-7 breast cancer cells. PBMC were not altered by colloidal silver.ConclusionsThe present results showed that colloidal silver might be a potential alternative agent for human breast cancer therapy.


Journal of Drug Targeting | 2005

Cell-surface display of E7 antigen from human papillomavirus type-16 in Lactococcus lactis and in Lactobacillus plantarum using a new cell-wall anchor from lactobacilli.

Vasco Azevedo; Juan Manuel Alcocer-González; Cristina Rodríguez-Padilla; Reyes Tamez-Guerra; Gérard Corthier; Alexandra Gruss; Philippe Langella; Luis G. Bermúdez-Humarán

The human papillomavirus type-16 (HPV-16) E7 protein is considered a major viral oncoprotein involved in cervical cancer (CxCa) and a potential candidate for the development of a vaccine against this neoplasia. Here, two lactic acid bacteria (the model one Lactococcus lactis and a probiotic one Lactobacillus plantarum) were engineered to deliver an E7 mutant protein (E7mm), which has a reduced transforming activity and consequently, could fit better to therapeutic use in humans than the native form of E7. An efficient cell-surface display of E7mm was obtained in L. lactis using an expression cassette encoding a precursor composed of (i) the signal peptide and the first 15 amino acids of the mature part of the lactococcal Usp45 protein; (ii) E7mm and (iii) the cell-wall anchor of the Streptococcus pyogenes M6 protein (CWAM6). This hybrid precursor was produced but not cell-wall anchored in Lb. plantarum. We thus replaced CWAM6 by the cell-wall anchor of a Lb. plantarum protein which allows an efficient cell-wall anchoring of E7mm in this bacterium. The E7mm production and cell-surface display in both L. lactis and a probiotic bacterium, Lb. plantarum, represent one more step towards the development of a safe and effective treatment against CxCa.


Phytotherapy Research | 2000

Immunoenhancing properties of Plantago major leaf extract.

R. Gomez-Flores; C. L. Calderon; L. W. Scheibel; Patricia Tamez-Guerra; Cristina Rodríguez-Padilla; Reyes Tamez-Guerra; R. J. Weber

Plantago major (PM), also known as plantain, is a weed found in temperate zones worldwide. PM leaves have been associated with various biological properties ranging from antiinflammatory, antimicrobial and antitumour to wound healing. However, its mechanism of action associated with boosting of the immune function remains to be elucidated. We found that endotoxin‐free methanol extracts from PM leaves, at doses of 50, 100, 250, and 500 µg/mL, were associated with 4.4 ± 1, 6 ± 1, 12 ± 0.4, and 18 ± 0.4‐fold increases of nitric oxide (NO) production, and increased TNF‐α production (621 ± 31, 721 ± 36, 727 ± 36, and 1056 ± 52 U/mL, respectively) by rat peritoneal macrophages, in the absence of IFN‐γ or LPS. NO and TNF‐α production by untreated macrophages was negligible. In addition, PM extracts potentiated Con A‐induced lymphoproliferation (3‐ to 12‐fold increases) in a dose‐dependent fashion, compared with the effect of ConA alone. The regulation of immune parameters induced by plant extracts may be clinically relevant in numerous diseases including chronic viral infections, tuberculosis, AIDS and cancer. Copyright


Intervirology | 2007

Mouse Mammary Tumor Virus-Like Gene Sequences in Breast Cancer Samples of Mexican Women

Pablo Zapata-Benavides; Santiago Saavedra-Alonso; Diana E. Zamora-Avila; C. Vargas-Rodarte; R. Barrera-Rodríguez; J. Salinas-Silva; Cristina Rodríguez-Padilla; Reyes Tamez-Guerra; Laura M. Trejo-Avila

Background: Previous reports related the presence of mouse mammary tumor virus (MMTV)-like gene sequences to human breast carcinoma. The aim of this study was to determine whether MMTV-like env gene sequences are present in breast cancer samples of Mexican women and in breast and lung cancer cell lines. Methods: Using specific primers for MMTV, we tested 3 breast cancer cell lines, 4 non-small lung cancer cell lines and 119 breast cancer samples from Mexican women. Results: MMTV-like gene sequences were amplified in the lung cancer cell INER-51, but not in the MCF-7 cell line that has been used as a positive control in other reports and in 5 of 119 (4.2%) breast cancer biopsy tissues. Furthermore, the identity of sequences of PCR products from INER-51 and a breast cancer-positive sample are 98 and 99% when compared with the env region of MMTV (GenBank accession No. AY161347). Conclusion: These results indicate that MMTV-like gene sequences are present in the Mexican population.


Journal of Invertebrate Pathology | 2008

Detection of genes encoding antimicrobial peptides in Mexican strains of Trichoplusia ni (Hübner) exposed to Bacillus thuringiensis

Patricia Tamez-Guerra; J. A. Valadez-Lira; Juan Manuel Alcocer-González; Brenda Oppert; Ricardo Gomez-Flores; Reyes Tamez-Guerra; Cristina Rodríguez-Padilla

The systemic immune response of Trichoplusia ni after Bacillus thuringiensis (Bt) exposure was evaluated by comparing the expression of genes encoding antimicrobial peptides (AMPs) in Bt-susceptible and -resistant T. ni strains that were either exposed or not to XenTari (Bt-XT). AMP genes were detected by RT-PCR using primers for attacin, gloverin, lebocin, lysozyme, and peptidoglycan recognition peptide (PGRP). In general, AMP genes were detected more frequently in Mexican field strains previously exposed to Bt (SALX and GTOX) than in a Mexican laboratory strain (NL), but expression was similar to the AMP expression in USA laboratory strains (US and USX). Among the AMPs, transcripts for lebocin were the least detected (11.7%) and those for lysozyme were the most detected (84.8%) in all samples. Lebocin was detected only in 2nd instar and pupa. All untreated controls expressed attacin. Attacin and gloverin were not detected in any midgut sample, and their highest detection was in pupa. Lysozyme was rarely detected in 2nd instar larvae from any strain or treatment but was detected in almost all midgut and hemolymph samples. Overall, AMPs were found more in T. ni strains previously exposed to Bt-XT, especially lebocin and globerin (1.8-fold increase) and PGRP (3.8-fold increase). The data suggest that the expression of AMPs in T. ni correlates to previous Bt exposure.


Cytotherapy | 2006

In vitro effects of bovine dialyzable leukocyte extract (bDLE) in cancer cells

Moisés Armides Franco-Molina; Edgar Mendoza-Gamboa; Diana F. Miranda-Hernández; Pablo Zapata-Benavides; Leonardo Castillo-León; C.E. Isaza-Brando; Reyes Tamez-Guerra; Cristina Rodríguez-Padilla

BACKGROUND Bovine dialyzable leukocyte extract (bDLE) is a dialyzate of a heterogeneous mixture of low molecular weight substances released from disintegrated blood leukocytes or lymphoid tissue obtained from homogenized bovine spleen. The purpose of this study was to determine if bDLE had cytotoxic effects and modulated apoptosis gene expression in breast cancer cells. METHODS The MCF-7, BT-474, MDA-MB-453, A-427, Calu-1, U937 and L5178Y cancer cell lines and PBMC human cells were treated with bDLE (0-0.66 U/mL) for 72 h. The bDLE effect on cell growth proliferation was evaluated by MTT assay, and the MCF-7 was evaluated by ethidium bromide-acridine orange staining; total DNA was evaluated for DNA fragmentation, and total RNA was isolated for p53, bag-1, c-myc, bim, bax, bcl-2 and bad mRNA expression. RESULTS The bDLE had dose-dependent cytotoxic effects and demonstrated an IC50 at a dosage of 0.06 U/mL (P<0.05). The bDLE did not affect the viability of normal human PBMC. The bDLE induced DNA fragmentation at doses of 0.06 and 0.13 U/mL in MCF-7 breast cancer cells. The bDLE induced cytotoxic effects and suppressed the p53, bag-1, c-myc, bax, bcl-2, and bad mRNA expression that influences apoptosis in MCF-7 breast cancer cells. Bim mRNA expression was not detected. DISCUSSION This may open up interesting prospects for the treatment of human breast cancer.


Molecules | 2012

Bioassay-Guided Isolation and Identification of Cytotoxic Compounds from Gymnosperma glutinosum Leaves

Ramiro Quintanilla-Licea; Rolando Morado-Castillo; Ricardo Gomez-Flores; Hartmut Laatsch; María Julia Verde-Star; Humberto Hernández-Martínez; Patricia Tamez-Guerra; Reyes Tamez-Guerra; Cristina Rodríguez-Padilla

Bioassay-guided fractionation of hexane extracts of Gymnosperma glutinosum (Asteraceae) leaves, collected in North Mexico, afforded the known compounds hentriacontane (1) and (+)-13S,14R,15-trihydroxy-ent-labd-7-ene (2), as well as the new ent-labdane diterpene (−)-13S,14R,15-trihydroxy-7-oxo-ent-labd-8(9)-ene (3). In addition, D-glycero-D-galactoheptitol (4) was isolated from the methanolic extract of this plant. Their structures were established on the basis of high-field 1D- and 2D NMR methods supported by HR-MS data. The cytotoxic activity was determined by using the in vitro L5178Y-R lymphoma murine model. Hentriacontane (1) and the new ent-labdane 3 showed weak cytotoxicity, whereas the ent-labdane 2 showed significant (p < 0.05) and concentration dependent cytotoxicity (up to 78%) against L5178Y-R cells at concentrations ranging from 7.8 to 250 µg/mL.


Leukemia & Lymphoma | 2003

Cellular Pharmacology of P-ethoxy Antisense Oligonucleotides Targeted to Bcl-2 in a Follicular Lymphoma Cell Line

Yolanda Gutiérrez-Puente; Ana M. Tari; Richard J. Ford; Reyes Tamez-Guerra; Roberto Mercado-Hernández; Santoyo-Stephano Ma; Gabriel Lopez-Berestein

A P-ethoxy oligonucleotide (oligo), 20 bases long and specific for the translation initiation site of human Bcl-2 mRNA, was incorporated into liposomes to increase its intracellular delivery. This oligo selectively inhibited Bcl-2 protein expression and induced growth inhibition in t(14;18)-positive transformed follicular lymphoma (FL) cell lines. We studied the inhibitory effects of shorter liposomal P-ethoxy oligos (7, 9, 11 or 15 mer) in order to determine the activity of different oligo chain lengths targeted to the same Bcl-2 mRNA. At 12 μM, all the oligos inhibited the growth of a FL cell line. We compared the 7-mer oligo with the 20-mer oligo. The two oligos inhibited Bcl-2 protein expression similarly: 66% and 60% for the 7- and 20-mer, respectively. The uptake and retention of both oligos were also very similar. Our results indicate that the Bcl-2 inhibitory activity is maintained with P-ethoxy antisense oligos ranging from 7 to 20 bases.

Collaboration


Dive into the Reyes Tamez-Guerra's collaboration.

Top Co-Authors

Avatar

Cristina Rodríguez-Padilla

Universidad Autónoma de Nuevo León

View shared research outputs
Top Co-Authors

Avatar

Ricardo Gomez-Flores

University of Illinois at Chicago

View shared research outputs
Top Co-Authors

Avatar

Patricia Tamez-Guerra

Universidad Autónoma de Nuevo León

View shared research outputs
Top Co-Authors

Avatar

Moisés Armides Franco-Molina

Universidad Autónoma de Nuevo León

View shared research outputs
Top Co-Authors

Avatar

Edgar Mendoza-Gamboa

Universidad Autónoma de Nuevo León

View shared research outputs
Top Co-Authors

Avatar

Pablo Zapata-Benavides

Universidad Autónoma de Nuevo León

View shared research outputs
Top Co-Authors

Avatar

Juan Manuel Alcocer-González

Universidad Autónoma de Nuevo León

View shared research outputs
Top Co-Authors

Avatar

Ramiro Quintanilla-Licea

Universidad Autónoma de Nuevo León

View shared research outputs
Top Co-Authors

Avatar

Diana F. Miranda-Hernández

Universidad Autónoma de Nuevo León

View shared research outputs
Top Co-Authors

Avatar

Erika Evangelina Coronado-Cerda

Universidad Autónoma de Nuevo León

View shared research outputs
Researchain Logo
Decentralizing Knowledge